Biovaxys Technology Income Statement

BIOV C$0.44 0.0 6.0%

05/03/21

Speculative, Micro Cap, Sucker Stock

Market Cap £17.9m

Enterprise Value £17.5m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Biovaxys Technology's income statement please upgrade your membership.

	2018	2019
Period End:	2018-10-31	2019-10-31
Period Length:	12M	12M
Currency:	CAD	CAD

Total Revenue


Selling/General/Administrative Expenses, Total
Unusual Expense (Income)

Total Operating Expense
Operating Profit/Income

Total Non Operating Interest Expense
Income Before Tax
Income After Tax

Net Income Before Extra. Items
Net Income

Income Available to Common Excl. Extra. Items
Income Available to Common Incl. Extra. Items
Diluted Net Income
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Incl. Extraordinary Items
Diluted EPS Excluding Extraordinary Items

Normalized Income Before Taxes
Normalized Income After Taxes
Normalized Inome Avail to Common Stock
Diluted Normalized EPS

Dividends per Share - Common Stock Primary Issue

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.